Stendra

FDA Building 2

Marketing

FDA rebukes Metuchen for 'misleading' Stendra ads

Touting an off-label use is a big no-no in pharma marketing, and that's exactly what's landed Metuchen Pharmaceuticals in trouble with the FDA.

Beth Snyder Bulik Aug 29, 2019 4:03pm

Sanofi

Sanofi wipes its hands of Vivus ED med Stendra

Mar 29, 2017 9:55am

alone

Post-Endo pact, will Vivus market Stendra solo--and should it?

Aug 5, 2016 11:43am